0001209191-19-039454.txt : 20190628
0001209191-19-039454.hdr.sgml : 20190628
20190628152526
ACCESSION NUMBER: 0001209191-19-039454
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190628
FILED AS OF DATE: 20190628
DATE AS OF CHANGE: 20190628
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Smith Scott Andrew
CENTRAL INDEX KEY: 0001614975
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37718
FILM NUMBER: 19929040
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Spring Bank Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001566373
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 522386345
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
BUSINESS PHONE: 508-473-5993 X119
MAIL ADDRESS:
STREET 1: 35 PARKWOOD DRIVE
STREET 2: SUITE 210
CITY: HOPKINTON
STATE: MA
ZIP: 01748
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-28
0
0001566373
Spring Bank Pharmaceuticals, Inc.
SBPH
0001614975
Smith Scott Andrew
C/O SPRING BANK PHARMACEUTICALS, INC.
35 PARKWOOD DRIVE
HOPKINTON
MA
01748
1
0
0
0
Common Stock
2019-06-28
4
P
0
12000
4.09
A
13883
D
This transaction was executed in multiple trades at prices ranging from $3.94 to $4.10 per share. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
/s/ Lori Firmani, attorney-in-fact
2019-06-28